RBC Capital Reiterates Outperform on HCA Healthcare, Maintains $435 Price Target

Benzinga Newsdesk www.benzinga.com Negative 94.1%

Neg 94.1% Neu 0% Pos 0%

RBC Capital analyst Ben Hendrix reiterates HCA Healthcare (NYSE:HCA) with a Outperform and maintains $435 price target.

Comments

No comments yet. Be the first!